Unknown PHASE4 INTERVENTIONAL 2-arm NCT02198027

Peritubal Infiltration of Bupivacaine in PCNL

Role of Peritubal Infiltration of 0.25% Bupivacaine in Percutaneous Nephrolithotomy (PCNL) in Postoperative Pain Control

Sponsor: Indus Hospital and Health Network

Conditions Pain

Interventions Bupivacaine Normal saline infiltration

Updated 6 times since 2017 Last updated: Sep 20, 2014 Started: Jul 31, 2014 Primary completion: Dec 31, 2014 Completion: Dec 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02198027, this PHASE4 trial focuses on Pain and remains ongoing. Sponsored by Indus Hospital and Health Network, it has been updated 6 times since 2014, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE4
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE4

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status PHASE4
Jan 2021 — Oct 2021 [monthly]

Unknown Status PHASE4
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE4

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE4

First recorded

Jul 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Indus Hospital and Health Network

Data source: Indus Hospital and Health Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Karachi, Pakistan